CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma
Clinical trial NCT03488160 · UNKNOWN
Trial details
- NCT number
- NCT03488160
- Sponsor
- Sinobioway Cell Therapy Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2019-04-10
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.